CXCR7 in tumorigenesis and progression

Chinese Journal of Cancer

Volumn 29, Issue 4, 2010, Pages 456-459

  Hou, Kai Lin ^a   Hao, Ming Gang ^b   Bo, Juan Jie ^a   Wang, Jian Hua ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chemokine; CXCR7; Progression; Tumorigensis

Indexed keywords

CANCER ANTIBODY; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CXCL11 CHEMOKINE; HERMES ANTIGEN; SMALL INTERFERING RNA; SMALL MOLECULE TRANSPORT AGENT; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; APOPTOSIS; BINDING AFFINITY; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; ESOPHAGUS CANCER; GLIOMA; HUMAN; KIDNEY CANCER; LUNG CANCER; MELANOMA; METASTASIS; NONHUMAN; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

EID: 79551615233     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10404     Document Type: Review

References (31)

1. Zlotnik A, M orales J, Hedrick JA. Recent advances in chemokines and chemokine receptors [J]. Crit Rev Immunol, 1999,19(1):1-47.
2. Homey B, Muller A, Zlotnik A. Chemokines: agents for the immunotherapy of cancer [J]. Nat Rev Immunol, 2002,2(3):175-184.
3. Baggiolini M, Dewald B, Moser B. Human chemokines:an update [J]. Annu Rev Immunol, 1997,15:675-705.
4. Balkwill F. Chemokine biology in cancer [J]. Semin Immunol, 2003,15(1): 49-55.
5. Balkwill F. Cancer and the chemokine network [J].Nat Rev Cancer, 2004,4(7):540-550.
6. Ben-B aruch A. The multifaceted roles of chemokines in malignancy [J]. Cancer Metastasis Rev, 2006,25(3):357-71.
7. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells [J]. Annu Rev Immunol, 2004,22:891-928.
8. Rossi D, Zlotnik A. The biology of chemokines and their receptors [J]. Annu Rev Immunol, 2000,18:217-242.
9. Raman D,Baugher PJ, Thu YM. et al.Role of chemokines in tumor growth [J]. Cancer Lett, 2007,256 (2):137-165.
10. Libert F, Parmentier M, Lefort A, et al. Complete nucleotide sequence of a putative G protein coupled receptor: RDC1 [J]. Nucleic Acids Res, 1990,18(7):1917.
11. Sreedharan SP, Robichon A, Peterson KE, et al. Goetzl.Cloning and expression of the human vasoactive intestinal peptide receptor [J]. Proc Natl Acad Sci USA, 1991,88(11):4986-4990.
12. Nagata S, Ishihara T, Robberecht P, et al.RDC1 may not be VIP receptor [J].Trends Pharmacol Sci, 1992 13(3):102-103.
13. Libert F, Passage E, Parmentier M, et al. Chromosomal mapping of A1 and A2 adenosine receptors,VIP receptor, and a new subtype of serotonin receptor [J]. Genomics, 1991,11(1):225-227.
14. McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-re captor-lik e receptor [J]. Nature, 1998, 393(6683):333-339.
15. Shimizu N, Soda Y, Kanbe K, et al. A putative G viruses [J].J Virol, 2000,74(2):619-626.
16. Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF-1/ CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J]. J Biol Chem, 2005,280(42):35760-35766.
17. Miao Z, Luker KE, Summers BC, et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-as sociated vasculature [J]. Proc Natl Acad Sci USA, 2007,104(40):15735-15740.
18. Goldmann T, Dromann D, Radtke J, et al. CXCR7 transcription in human non-small cell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy [J]. Virchows Arch, 2008,452(3):347-348.
19. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TA C involved in cell survival, cell adhesion, and tumor development [J]. J Exp Med, 2006,203(9):2201-2213.
20. Wang J, Shiozawa Y, Wang J, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer [J].J Biol Chem, 2008,283(7):4283-4294.
21. Iwakiri S, Mino N, Takahashi T, et al. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer [J]. Cancer, 2009,115(11): 2580-2593.
22. Meijer J, Ogink J, Roos E, Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo [J]. Br J Cancer, 2008,99(9):1493-1501.
23. Madden SL, Cook BP, Nacht M, et al. Vascular gene expression in nonneoplastic and malignant brain [J]. Am J Pathol, 2004,165 (2):601-608.
24. Naor D, Wallach-Dayan SB, Zahalka MA, et al. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination [J]. Semin Cancer Biol, 2008,18(4):260-267.
25. Puré E, Assoian RK. Rheostatic signaling by CD44 and hyaluronan [J]. Cell Signal, 2009,21(5):651-655.
26. Zhang Y, Wen G, Shao G, et al. TGFBI deficiency predisposes mice to spontaneous tumor development [J].Cancer Res, 2009,69(1):37-44.
27. Van Rechem, Rood BR, Touka M, et al. The scavenger chemokine (C-X - C motif) receptor7 CXCR7 is a direct target gene of hypermethylated in cancer 1 HIC1 [J]. J Biol Chem, 2009, 284(31):20927-20935.
28. Sierro F, Biben C, Martinez-Munoz L, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 [J]. Proc Natl Acad Sci USA, 2007,104 (37):14759-14764.
29. Levoye A, Balabanian K, Baleux F, et al. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-m ediated G protein signalling [J].Blood, 2009, 113(24):6085-1193.
30. Aman A, Piotrowski T. Wnt/β-C atenin and Fgf signaling control collective cell migration by restricting chemokine receptor expression [J]. Dev Cell, 2008,15(5):749-761.
31. Mazzinghi B, Ronconi E, Lazzeri E, et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells [J]. J Exp Med, 2008,205(2):479-490.